Feasibility of cytomegalovirus antigenemia test in the endoscopically-biopsied gastrointestinal mucosa

Feasibility of cytomegalovirus antigenemia test in the endoscopically-biopsied gastrointestinal mucosa - Cytomegalovirus antigenemia test and endoscopic biopsy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037897

Enrollment

Registered

2019-09-02

Start date

2019-09-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cytomegalovirus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with clinically suspected gastrointestinal CMV infection who are scheduled to undergo endoscopy and endoscopic biopsy

Exclusion criteria

Exclusion criteria: Women who are pregnant or may be pregnant

Design outcomes

Primary

Measure	Time frame
To compare immunostaining results (histological diagnosis) of patients with gastrointestinal CMV infection and CMV antigenemia analysis results of the endoscopically-biopsed tissues	—

Countries

Japan

Contacts

Public ContactMasaya Iwamuro

Okayama University Hospital Department of Gastroenterology and Hepatology

iwamuromasaya@yahoo.co.jp0862357218

Outcome results